Ionis Pharma (IONS) Misses Q4 EPS Views

Ionis Pharma (NASDAQ: IONS) reported Q4 EPS of ($0.59), $0.11 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $51.6 million versus the consensus estimate of $49.32 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance